Contact us

Leader in human milk nutrition

Established in 1999, Prolacta Bioscience is a privately held life sciences company that has touched the lives of more than 63,000 premature infants globally.1

Dedicated to advancing the science of human milk, we employ more than 300 people throughout the world, many of whom have dedicated their lives to neonatal care.

Together, we’re just as committed to ethical business practices, protecting the safety of our team, and fostering an inclusive culture.

Ethical Practices

As we work to bring life-saving nutrition to critically ill and premature infants, we’re also committed to ethical business practices, protecting the safety of our team, and fostering an inclusive culture.

Prolacta is the world’s leading hospital provider of 100% human milk–based nutritional products.

Available to hospitals since 2006, our fortifiers changed the standard of care for extremely premature infants worldwide and remain the first and only nutritional fortifiers made from 100% donor milk instead of cow milk.

We are also exploring the therapeutic potential of human milk including applications for infants who need surgery for congenital cardiac and gastrointestinal disorders.

Learn how we ensure safety

We lead the human milk industry in the steps we take to ensure quality and safety

Join our team

Together, we can save the lives of even more infants

Meet our leadership team

People dedicated to living up to our mission and improving the lives of babies

Advancing the science of human milk®


As part of this commitment, we sponsor the International Conference on Human Milk Science and Innovation, a forum for the latest scientific and clinical research related to human milk. The annual conference hosts renowned scientists and neonatologists from around the world. We also work closely with clinicians and researchers to add to the growing scientific evidence on health benefits of human milk.

Prolacta feed

Providing Safe Nutritional Products During the Coronavirus Outbreak

Read more

Prolacta feed

Multiple NICUs Showed Improved Growth & Lung Health in Premature Infants by Fortifying Feeds Safely in the First Days of Life with Prolacta’s 100% Human Milk-Based Fortifiers

Read more

Prolacta feed

The Preemie Parent’s Survival Guide to the NICU Now Reflects the Latest Clinical Advancements to Better Support Parents Worldwide

Read more

Presss + news

See all
  • Press releases
  • Prolacta in the news

Multiple NICUs Showed Improved Growth & Lung Health in Premature Infants by Fortifying Feeds Safely in the First Days of Life with Prolacta’s 100% Human Milk-Based Fortifiers

The Preemie Parent’s Survival Guide to the NICU Now Reflects the Latest Clinical Advancements to Better Support Parents Worldwide

Head-to-Head Subgroup Analysis of Human Milk–Based Fortifiers Finds Significant Improvements in Health and Brain Growth Measure for Preemies Fed Mother’s Milk Plus Prolacta’s Fortifiers

Prolacta Bioscience Reassures Hospitals of the Safety of Its Human Milk-Based Nutritional Products During the Coronavirus Pandemic

Microbiome and Gut-Brain Axis in Premature Infants Focus of 2020 International Conference on Human Milk Science and Innovation

Upcoming events

All events

Citations